Novel biomarkers and age-related metabolite correlations in plasma and dried blood spots from patients with succinic semialdehyde dehydrogenase deficiency.
Acylcarnitines
Age-dependent correlations
Amino acids
Creatinine, guanidinoacetate
Dried blood spots
γ-Aminobutyrate (GABA)
γ-Hydroxybutyrate (GHB)
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
23 09 2020
23 09 2020
Historique:
received:
11
05
2020
accepted:
24
08
2020
entrez:
24
9
2020
pubmed:
25
9
2020
medline:
19
5
2021
Statut:
epublish
Résumé
Previous work has identified age-related negative correlations for γ-hydroxybutyric acid (GHB) and γ-aminobutyric acid (GABA) in plasma of patients with succinic semialdehyde dehydrogenase deficiency (SSADHD). Using plasma and dried blood spots (DBS) collected in an ongoing natural history study, we tested the hypothesis that other biomarkers would follow a similar age-related negative correlation as seen for GHB/GABA. Samples (mixed sex) included: patients (n = 21 unique samples, 1-39.5 yrs) and parallel controls (n = 9 unique samples, 8.4-34.8 yrs). Archival control data (DBS only; n = 171, 0.5-39.9 yrs) was also included. Metabolites assessed included amino acids (plasma, DBS) and acylcarnitines, creatine, creatinine, and guanidinoacetate (DBS only). Age-related negative correlations for glycine (plasma, DBS) and sarcosine (N-methylglycine, plasma) were detected, accompanied by elevated proline and decreased levels of succinylacetone, argininosuccinate, formaminoglutamate, and creatinine. Significantly low acylcarnitines were detected in patients across all chain lengths (short-, medium- and long-chain). Significant age-dependent positive correlations for selected acylcarnitines (C6-, C12DC(dicarboxylic)-, C16-, C16:1-, C18:1-, C18:2OH-carnitines) were detected in patients and absent in controls. Receiver operating characteristic (ROC) curves for all binary comparisons revealed argininosuccinate and succinylacetone to be the most discriminating biomarkers (area > 0.92). Age-dependent acylcarnitine correlations may represent metabolic compensation responsive to age-related changes in GHB and GABA. Our study highlights novel biomarkers in SSADHD and expands the metabolic pathophysiology of this rare disorder of GABA metabolism.
Sections du résumé
BACKGROUND
Previous work has identified age-related negative correlations for γ-hydroxybutyric acid (GHB) and γ-aminobutyric acid (GABA) in plasma of patients with succinic semialdehyde dehydrogenase deficiency (SSADHD). Using plasma and dried blood spots (DBS) collected in an ongoing natural history study, we tested the hypothesis that other biomarkers would follow a similar age-related negative correlation as seen for GHB/GABA. Samples (mixed sex) included: patients (n = 21 unique samples, 1-39.5 yrs) and parallel controls (n = 9 unique samples, 8.4-34.8 yrs). Archival control data (DBS only; n = 171, 0.5-39.9 yrs) was also included.
RESULTS
Metabolites assessed included amino acids (plasma, DBS) and acylcarnitines, creatine, creatinine, and guanidinoacetate (DBS only). Age-related negative correlations for glycine (plasma, DBS) and sarcosine (N-methylglycine, plasma) were detected, accompanied by elevated proline and decreased levels of succinylacetone, argininosuccinate, formaminoglutamate, and creatinine. Significantly low acylcarnitines were detected in patients across all chain lengths (short-, medium- and long-chain). Significant age-dependent positive correlations for selected acylcarnitines (C6-, C12DC(dicarboxylic)-, C16-, C16:1-, C18:1-, C18:2OH-carnitines) were detected in patients and absent in controls. Receiver operating characteristic (ROC) curves for all binary comparisons revealed argininosuccinate and succinylacetone to be the most discriminating biomarkers (area > 0.92).
CONCLUSIONS
Age-dependent acylcarnitine correlations may represent metabolic compensation responsive to age-related changes in GHB and GABA. Our study highlights novel biomarkers in SSADHD and expands the metabolic pathophysiology of this rare disorder of GABA metabolism.
Identifiants
pubmed: 32967698
doi: 10.1186/s13023-020-01522-5
pii: 10.1186/s13023-020-01522-5
pmc: PMC7510106
doi:
Substances chimiques
Biomarkers
0
Succinate-Semialdehyde Dehydrogenase
EC 1.2.1.24
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
261Subventions
Organisme : NICHD NIH HHS
ID : U54 HD090255
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD091142
Pays : United States
Références
Neurobiol Dis. 2004 Aug;16(3):556-62
pubmed: 15262267
J Inherit Metab Dis. 1987;10(4):367-75
pubmed: 3126356
J Neurochem. 2007 Dec;103(5):2077-91
pubmed: 17854388
Clin Chem. 2008 Apr;54(4):657-64
pubmed: 18281422
Biochim Biophys Acta. 2006 Apr;1762(4):494-8
pubmed: 16504488
J Inherit Metab Dis. 2019 Sep;42(5):1030-1039
pubmed: 31032972
Front Cell Neurosci. 2019 Nov 19;13:517
pubmed: 31803026
J Inherit Metab Dis. 2016 Nov;39(6):795-800
pubmed: 27686230
Ann Clin Transl Neurol. 2018 Dec 03;6(1):114-120
pubmed: 30656189
Biol Psychiatry. 2004 Mar 1;55(5):452-6
pubmed: 15023571
Neurochem Int. 2007 Mar;50(4):653-9
pubmed: 17303287
Mol Genet Metab. 2019 Dec;128(4):397-408
pubmed: 31699650
Neurochem Int. 2019 May;125:151-162
pubmed: 30822440
JIMD Rep. 2019;43:13-17
pubmed: 29480352
Front Psychiatry. 2020 Apr 02;11:166
pubmed: 32300311
JIMD Rep. 2020 Feb 26;53(1):29-38
pubmed: 32395407
Metab Brain Dis. 2020 Apr;35(4):601-614
pubmed: 32172518